Crispr has been making waves with its success in fighting rare genetic diseases, but could it also help turn bacterium’s machinery against itself? In the era of superbugs, scientists are hopeful the technology can be a game-changer. Meanwhile, GSK has announced a late-stage study for its new antibiotic to fight urinary tract infections and gonorrhoea.
from Kaiser Health News https://ift.tt/2ow3hgU
October 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
KHN’s ‘What the Health?’: ACA in Peril With Ginsburg’s Seat in PlayCan’t see the audio player? Click here to listen on SoundCloud. The death of Supreme Court Justice Ruth Bader Ginsburg — and the insistence of President Donald Trump and the GOP-led Senate to fill that vacancy this year … Read More
These Secret Safety Panels Will Pick the COVID Vaccine WinnersMost Americans have never heard of Dr. Richard Whitley, an expert in pediatric infectious diseases at the University of Alabama-Birmingham. Yet as the coronavirus pandemic drags on and the public eagerly awaits a vaccine, he … Read More
As Fires and Floods Wreak Havoc on Health, New Climate Center Seeks SolutionsFor the past month, record-breaking wildfires have torched millions of acres from the Mexican border well into Canada, their smoke producing air so toxic that millions of people remained indoors for days on end while many vis… Read More
A Fair to Remember: County Fairs Weigh Risk of Outbreak Against Financial RuinLaura Stutzman had no doubts that this year’s Twin Falls County Fair should go on despite the pandemic still raging across the U.S. — and several outbreaks tied to such community fairs. Though she saw few people wearing masks… Read More
California Expands Privacy Protection to Public Health Workers Amid ThreatsSANTA CRUZ, Calif. — California will allow public health officials to participate in a program to keep their home addresses confidential, a protection previously reserved for victims of violence, abuse and stalking and reprod… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment